Dr. Chung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
Fl 4
San Francisco, CA 94143Phone+1 415-353-2421Fax+1 650-498-6205
Education & Training
- Northwestern University The Feinberg School of MedicineClass of 2014
Certifications & Licensure
- CA State Medical License 2015 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 35 citationsOrgan responses with daratumumab therapy in previously treated AL amyloidosis.Alfred Chung, Gregory P. Kaufman, Surbhi Sidana, Erik Eckhert, Stanley L. Schrier
Blood Advances. 2020-02-11 - 5 citationsAntibody and T-cell responses by ultra-deep T-cell receptor immunosequencing after COVID-19 vaccination in patients with plasma cell dyscrasias.Alfred Chung, Barbara Banbury, Marissa Vignali, Chiung-Yu Huang, Sireesha Asoori
British Journal of Haematology. 2022-11-01 - 5 citationsSalvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma.Kevin R Reyes, Yen-Chun Liu, Chiung-Yu Huang, Rahul Banerjee, Thomas Martin
Blood Advances. 2024-05-14
Lectures
- Favorable Long-Term Outcomes after Daratumumab Discontinuation in AL Amyloidosis Patients Achieving Deep Responses61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Long-Term Outcomes and Organ Responses with Daratumumab Therapy in Previously Treated Patients with AL Amyloidosis61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: